GeoVax Labs
GOVX
8 hedge funds and large institutions have $481K invested in GeoVax Labs in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0.41% more ownership
Funds ownership: 0.03% → 0.44% (+0.41%)
33% less funds holding
Funds holding: 12 → 8 (-4)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
58% less capital invested
Capital invested by funds: $1.13M → $481K (-$651K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$220K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$92.5K |
| 2 |
State Street
Boston,
Massachusetts
|
-$35.4K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$12.4K |
| 4 |
Renaissance Technologies
New York
|
-$10K |
| 5 |
WF
Welch & Forbes
Boston,
Massachusetts
|
-$6.13K |
GOVX Hedge Fund Activity: Q1 2024 in Review
8 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs (GOVX) for Q1 2024, worth a combined $481K — down 58% from $1.13M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GOVX and 0 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Armistice Capital, adding an estimated $220K. The largest seller was Vanguard Group, cutting an estimated $92.5K.
- 8 institutional investors held GeoVax Labs (GOVX) as of Q1 2024, down from 12 in Q4 2023.
- Funds reported $481K of GeoVax Labs stock for Q1 2024, down 58% quarter-over-quarter.
- 0 funds opened new GeoVax Labs positions in Q1 2024 and 4 closed out, a net change of -4 holders.
- The largest GeoVax Labs buyer in Q1 2024 was Armistice Capital, an estimated $220K added.
- The largest GeoVax Labs seller in Q1 2024 was Vanguard Group, an estimated $92.5K sold.
Based on aggregated 13F filings for Q1 2024.